Journal
JOURNAL OF IMMUNOLOGY
Volume 168, Issue 1, Pages 87-94Publisher
AMER ASSOC IMMUNOLOGISTS
DOI: 10.4049/jimmunol.168.1.87
Keywords
-
Categories
Funding
- NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI043540, T32AI007411] Funding Source: NIH RePORTER
- NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R03AR045770] Funding Source: NIH RePORTER
- NIAID NIH HHS [AI 43540, AI 07411] Funding Source: Medline
- NIAMS NIH HHS [AR 45770] Funding Source: Medline
Ask authors/readers for more resources
During development in the thymus, mature CD4(+) or CD8(+) cells are derived from immature CD4(+)CD8(+) cells through a series of selection events. One of the hallmarks of this maturation process is the expression of CD69, which first appears on thymocytes as they begin positive selection. We have used blockade and overexpression of CD69 to determine the role of CD69 in thymocyte development. Blockade of CD69 led to a reduction in single-positive cells and a concomitant increase in double-positive cells in the thymus. Overexpression of a CD69 transgene in the thymus resulted in a dramatic increase in both CD8SP and CD4SP cells. Coexpression with a TCR transgene demonstrated that both positive and negative selection were enhanced by the increased levels of CD69 on thymocytes. Finally, mice overexpressing CD69 displayed a sharp reduction in the number of T cells in the spleen and lymph node. Taken as a whole, these data suggest the involvement of CD69 in the process of selection and maturation during the trafficking of thymocytes to the medulla.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available